Moderna Inc.

Incorporated in 2010, Moderna is headquartered in Cambridge, Massachusetts, USA. The company has cemented its position in the pharmaceuticals and biotechnology industry, primarily concentrating on mRNA technology. Its chief business segment revolves around the development and commercialization of innovative therapies and vaccines. The most important brand under the Moderna umbrella is its COVID-19 vaccine, commonly referred to as the Moderna COVID-19 Vaccine or Spikevax. With a global reach, Moderna's products are sold in key markets across several countries. The United States, various European nations, Canada, and Japan stand out among these, either as locations where the COVID-19 vaccine is distributed or where their product candidates are in clinical evaluation stages. (Powered by AI)